MedTrace Logo

High Flow Nasal Oxygen During Sedation

NCT03858257 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2020-11-12

No results posted yet for this study

Summary

The primary objective of this study is to test the hypothesis that using high flow nasal oxygen improves ventilation during cardiac implantable electronic device procedures performed with conscious sedation. A randomized controlled trial design will be used with participants randomized in a 1:1 ratio to oxygen supplementation through a standard facemask or high flow nasal oxygen.

Conditions

  • Anesthesia
  • Cardiac Disease

Interventions

DEVICE

High flow nasal oxygen

The Optiflow device (Fisher and Paykel Healthcare, Auckland, New Zealand) will be used.

DEVICE

Standard oxygenation

Supplemental oxygen through a facemask.

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Aaron Conway, RN, PhD · University Health Network, Toronto

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-07
Primary Completion
2020-03-12
Completion
2020-03-12

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03858257 on ClinicalTrials.gov